Positive diagnostic strategy non-inferior to exclusion in IBS

August 9, 2013
Positive diagnostic strategy non-inferior to exclusion in IBS
For patients with irritable bowel syndrome, a positive diagnostic strategy is non-inferior to a strategy of exclusion for patients' health-related quality of life, according to a study published in the August issue of Clinical Gastroenterology and Hepatology.

(HealthDay)—For patients with irritable bowel syndrome (IBS), a positive diagnostic strategy is non-inferior to a strategy of exclusion for patients' health-related quality of life (HRQOL), according to a study published in the August issue of Clinical Gastroenterology and Hepatology.

Luise M. Begtrup, M.D., from Odense University in Denmark, and colleagues conducted a non-inferiority trial comparing a positive diagnostic strategy with a strategy of exclusion for patients' HRQOL. Participants included 302 patients (aged 18 to 50 years) from primary care who fulfilled the Rome III criteria for IBS with no alarm signals. They were randomized to groups to be assessed by exclusion (analyses of blood, stool samples for intestinal parasites, and sigmoidoscopies with biopsies) or a positive strategy involving and C-reactive protein. From baseline to one year, the difference in the change of HRQOL was assessed.

The researchers found that a positive strategy was non-inferior to an exclusion strategy (difference, 0.64). Lower direct costs were incurred with the positive diagnostic strategy. Similar effects on symptoms, satisfaction, and subsequent use of health resources were observed with each approach. There were no cases found of , colorectal cancer, or celiac disease.

"In diagnosing IBS in primary care, use of a positive diagnostic strategy is non-inferior to using a strategy of exclusion with regard to the patients' HRQOL," the authors write. "Our findings support the current guideline recommendations."

Explore further: Biomarkers can reveal irritable bowel syndrome

More information: Abstract
Full Text
Editorial

Related Stories

Biomarkers can reveal irritable bowel syndrome

May 7, 2012

Irritable bowel syndrome (IBS) is hard to diagnose as well as treat, but researchers at the Sahlgrenska Academy, at the University of Gothenburg, Sweden, have discovered a way of confirming the disorder using stool samples.

Researcher: Hypnosis should be offered to patients with IBS

December 18, 2012

Hypnotherapy helps fight IBS symptoms. These are the findings of a thesis from Sahlgrenska Academy, University of Gothenburg, Sweden which proposes implementing this treatment method into the care of severe sufferers of this ...

Spondylolisthesis sx improves pediatric health related-QOL

July 30, 2013

(HealthDay)—In pediatric patients with high-grade spondylolisthesis, health-related quality of life (HRQOL) improves significantly after surgery, especially in patients with low baseline HRQOL scores, according to a study ...

Recommended for you

Cellphone data can track infectious diseases

August 20, 2015

Tracking mobile phone data is often associated with privacy issues, but these vast datasets could be the key to understanding how infectious diseases are spread seasonally, according to a study published in the Proceedings ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.